高级检索
当前位置: 首页 > 详情页

Levels of Inflammatory Cytokines IL-1 beta, IL-6, IL-8, IL-17A, and TNF-alpha in Aqueous Humour of Patients with Diabetic Retinopathy

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Ophthalmology, ZhuJiang Hospital of Southern Medical University, Guangzhou 510280, China [2]Department of Ophthalmology, Guangdong Eye Institute, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China [3]Department of Ophthalmology, The First Affiliated Hospital of Kunming Medical College, Kunming 650031, China [4]Gejiu People’s Hospital, Gejiu 661000, China [5]The Second People’s Hospital of Jiangxi, Nanchang 330000, China
出处:
ISSN:

摘要:
Diabetic retinopathy is the leading cause of blindness in working age individuals in developed countries. However, the role of inflammation in the pathogenesis of DR is not completely understood. This is an observational clinical research enrolling 80 type II diabetic patients who had undergone cataract surgeries either with DR or without DR. All cases were further categorized by the proliferative stages of retinal neovascularization and by the lengths of diabetic history. The levels of inflammatory cytokines including IL-1 beta, IL-6, IL-8, IL-17, and TNF-alpha in aqueous humour were tested. Results in this study indicated that these cytokine levels were increased in DR patients and might have a synergistic effect on the pathogenesis of this disease. They were also elevated along with the progression of neovascularization, reflecting the severity of DR. The results also suggested that for diabetic patients, the higher these levels are, the sooner retinal complications might appear. In conclusion, the levels of inflammatory cytokines IL-1 beta, IL-6, IL-8, IL-17A, and TNF-alpha in aqueous humour may be associated with the pathogenesis, severity, and prognosis of DR.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2019]版:
大类 | 3 区 医学
小类 | 3 区 医学:研究与实验 4 区 内分泌学与代谢
最新[2025]版:
大类 | 3 区 医学
小类 | 3 区 内分泌学与代谢 3 区 医学:研究与实验
JCR分区:
出版当年[2018]版:
Q2 MEDICINE, RESEARCH & EXPERIMENTAL Q3 ENDOCRINOLOGY & METABOLISM
最新[2024]版:
Q2 ENDOCRINOLOGY & METABOLISM Q2 MEDICINE, RESEARCH & EXPERIMENTAL

影响因子: 最新[2024版] 最新五年平均 出版当年[2018版] 出版当年五年平均 出版前一年[2017版] 出版后一年[2019版]

第一作者:
第一作者机构: [1]Department of Ophthalmology, ZhuJiang Hospital of Southern Medical University, Guangzhou 510280, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:70856 今日访问量:0 总访问量:2273 更新日期:2025-12-01 建议使用谷歌、火狐浏览器 常见问题

技术支持:重庆聚合科技有限公司